Unclassified Renal Cell Carcinoma — knowledge graph · CancerIndex

Knowledge graph · Cancer

Unclassified Renal Cell Carcinoma

subtype

Identifier: CI-CAN-00009474
Entity page: /cancer/unclassified-renal-cell-carcinoma ↗
Edges: 11

Neighbours: 5 drugs6 trials
Drawn: 11 of 11 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Unclassified Renal Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived5 of 5
→ investigated in trials for	Cabozantinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants	—	—	Unclassified Renal Cell Carcinoma	4	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants

Unclassified Renal Cell Carcinoma studied in …STUDIED_INderived6 of 6
→ studied in	NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04413123Phase 2 · active not recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC · condition mapped ONTOLOGY_EXACT · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04603365Phase 2 · withdrawn Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer · condition mapped CURATED_BROADER · 6 trials mapped (5 active)	—	—	Unclassified Renal Cell Carcinoma	1	Observed	clinicaltrials	graph →